• Brunello Cucinelli raises its forecasts and launches its share buyback plan.
  • Hewlett Packard Enterprise loses 1% after its quarterly results.
  • HP Inc. plunges 10% after its quarterly results.
  • The JM Smucker posts mixed results for fiscal Q1, but revises upwards its full-year earnings target.
  • As part of the Inflation Reduction Act, the US government has published a list of 10 drugs whose prices will be negotiated by Medicare and drug manufacturers between October 2023 and August 2024, to take effect from 2026. Several major laboratories are involved (AstraZeneca, Novo Nordisk, Novartis, etc.).
  • European car sales up 15% in July, according to ACEA.
  • Apple holds its autumn event on September 12, with analysts expecting new iPhones.
  • Fitch confirms and withdraws Akzo Nobel's rating.
  • Demant plans to withdraw from the games segment amid volatile market conditions.
  • Burkhalter announces successful capital increase.
  • Orsted to write down DKK 5 bn ($730m) on its US portfolio.
  • Superdry will publish results late.
  • TPG acquires a majority stake in Crowe Healthcare Consulting for an undisclosed sum.
  • FedEx plans to raise rates in early 2024.
  • Intesa negotiates the purchase of First Bank in Romania for €200 million.
  • Fertilizer manufacturer Mosaic announced on Tuesday that CEO James O'Rourke will step down on December 31.
  • Kudelski signs partnership with US 2G Digital Post.
  • Coloplast seeks to raise DKK 9 bn via a private placement of B shares.
  • Major U.S. regional banks are expected to issue around $70 billion in new debt under a rule proposed Tuesday by U.S. banking regulators, aimed at bolstering the sector's resilience.
  • Tesla is down 1.4% in pre-market trading, after gaining over 11% in the last three sessions.
  • Box - The cloud computing company is down 9.8% after the close, as it forecasts third-quarter sales of $261 million to $263 million, compared with the $265.6 million average forecast by analysts.
  • PVH Corp rises by 1.5% after the close. Tommy Hilfiger's parent company is forecasting earnings of $10.35 per share for the fiscal year, compared with $10 previously, while analysts were expecting $10.02.
  • Mosaic is down 1.7% in pre-market trading following the announcement of the departure of its CEO James O'Rourke.
  • Fibrogen falls 14% after the close, as the drug developer reports that its experimental drug for Duchenne muscular dystrophy has failed to meet targets in a late-stage study.
  • Rite Aid fell by 6.3% before the opening, S&P Global having downgraded the company due to restructuring risks.
  • Ambarella - The chipmaker fell by nearly 20% before the stock market after reporting third-quarter sales of $50 million, well below Wall Street estimates of $67.6 million. TD Cowen downgrades its recommendation from "outperform" to "in-line performance".